---
DrugClass: "[[Cholinergic Blocking Drugs]]"
SubClass: "[[Cholinergic Blocking Drugs for Nonacute Respiratory Symptom Relief]]"
DrugClassContra: "[[Cholinergic Blocking Drugs#Contraindications]]"
DrugClassAdverse: "[[Cholinergic Blocking Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: "[[Lower Respiratory System Drugs]]"
SecondarySubClass: "[[Bronchodilators]]"
BrandName: Spiriva
Chapter: "26"
KindleLinkChap: "[Chapter 26](kindle://book?action=open&asin=B09FRF11YJ&location=13703)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Maintenance treatment of COPD
1 capsule per day using inhalation device, not for oral use

### Contraindications
See `= this.DrugClassContra`

### Interactionsse Effects
See `= this.DrugClassAdverse`
Same as [[revefenacin#Side/Adverse Effects]], increased stroke potential

### Interactions

`= this.ChemLink+this.file.name`

 